Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	310	253	59	90	70	99
Market Cap Growth	172.34%	332.31%	-35.03%	29.73%	-29.98%	-
Enterprise Value	285	218	28	64	31	46
Last Close Price	6.38	5.22	1.67	4.56	3.52	5.02
PS Ratio	28.53	23.34	8.22	8.03	54.32	169174.86
PB Ratio	13.26	10.85	2.82	5.50	2.12	1.90
P/TBV Ratio	13.26	10.85	2.82	5.50	2.12	1.90
EV/Sales Ratio	26.24	20.12	3.92	5.73	24.39	78418.50
Net Debt / Equity Ratio	-1.06	-1.06	-1.27	-1.79	-1.34	-1.00
Net Debt / EBITDA Ratio	1.39	1.39	1.57	1.72	2.27	4.00
Asset Turnover	0.40	0.40	0.25	0.29	0.03	0
Quick Ratio	6.75	6.75	4.01	2.16	3.27	21.04
Current Ratio	6.75	6.75	4.06	2.19	3.39	21.68
Return on Equity (ROE)	-78.89%	-78.89%	-86.68%	-66.66%	-45.72%	-42.00%
Return on Assets (ROA)	-40.79%	-40.79%	-36.55%	-27.94%	-23.95%	-24.36%
Return on Capital Employed (ROCE)	-76.80%	-76.80%	-81.30%	-104.20%	-59.00%	-25.10%
Earnings Yield	-5.62%	-6.87%	-27.49%	-18.18%	-27.96%	-13.21%
Buyback Yield / Dilution	-44.30%	-44.30%	-59.89%	0.40%	-23.97%	-32.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.